France· FR:60613673

OXYTOCINE PANPHARMA 5 UI/1 ml, solution injectable

A oxytocin product containing oxytocine, registered in France by PANPHARMA. The same ATC class is registered in 16 of our 19 countries.

ATC H01BB02

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxytocineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Oxytocin is registered in 16 of 19 countries.

Countries holding a registration under ATC H01BB02 (oxytocin), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
9 of them publish a price we can compare per daily dose

Search oxytocin products by name

Oxytocin · ATC H01BB02

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: OXYTOCINE
Manufacturer: PANPHARMA
Country: France (FR)
ATC code: H01BB02
ATC class: Oxytocin
Defined daily dose: 15 E, N
Reimbursed: No
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 1

cip13
3400958414190
10 ampoule(s) en verre de 1 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

303 interactions on record for oxytocin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxytocin against other medicines How interaction checks work

Oxytocin · interactions on record

303 records

71 severe
228 moderate
3 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxytocin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxytocin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Oxytocin Grindeks, Syntocinon
Belgium · Oxytocin Grindeks, Syntocinon
Bulgaria · Окситоцин Pихtep
Cyprus · Syntocinon
Czechia · Ofost, Oxytocin Avmc
Germany · Oxytocin Hexal, Oxytocin Panpharma
Denmark · Oxytocin Orifarm, Syntocinon
Estonia · Oxytocin Grindeks
Spain · Oxitocina Grindeks, Syntocinon
Finland · Oxytocin Orifarm, Syntocinon
United Kingdom (Northern Ireland) · Oxytocin, Oxytocin Hameln Pharma
Greece · Oxytocin Gap
Croatia · Syntocinon
Hungary · Oxytocin Grindeks, Oxytocin Panpharma
Ireland · Ofost, Oxytocin Pinewood Laboratories
Iceland · Syntocinon
Italy · Ossitocina Grindeks, Syntocinon
Lithuania · Ofost, Oxytocin Grindeks
Latvia · Ofost, Oxytocin Grindeks
Malta · Oxytocin Wockhardt, Syntocinon
Netherlands · Syntocinon
Norway · Oxytocin Cd Pharma, Oxytocin Orifarm
Poland · Oxytocin Grindeks, Oxytocin Grindex
Portugal · Oxitocina Generis, Oxitocina Grindeks
Romania · Ofost, Oxitocină Panpharma
Sweden · Oxytocin Cd Pharma, Oxytocin Grindeks
Slovenia · Ofost, Syntocinon
Slovakia · Ofost, Oxygrindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ad43a1f2-0211-4d2c-834c-7eff88720a6e
GET /v1/drugs/ad43a1f2-0211-4d2c-834c-7eff88720a6e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60613673",
  "date_amm": "2013-02-20",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "OXYTOCINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intra-murale;intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about oxytocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console